BDBM636677 US20230365627, Compound 1001

SMILES CCCC[C@H]1C(=O)N(C)[C@@H](CCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@H]2CNCc3cccc(c3)B(O)OC(=O)Cn3cc(c4ccccc43)C[C@H](NC(=O)[C@H](CCN)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(C)C)NC2=O)C(=O)N1C

InChI Key InChIKey=FSWWZHGAZSMERO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 636677   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 636677BDBM636677(US20230365627, Compound 1001)
Affinity DataIC50: 3.80nMAssay Description:Homogenous Time-Resolved Fluorescence (HTRF) Binding Assay. The interaction of PD-1 and PD-L1 can be assessed using soluble, purified preparations of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2024
Entry Details
US Patent